Azetidine-substituted pyridine and pyrazine compounds as inhibitors of cannabinoid receptor 2
US-12180196-B2 · Dec 31, 2024 · US
Pharmaceutical composition of an anthracycline
US8940334B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8940334-B2 |
| Application number | US-59933108-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 30, 2008 |
| Priority date | May 11, 2007 |
| Publication date | Jan 27, 2015 |
| Grant date | Jan 27, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to pharmaceutical composition containing nemorubicin hydrochloride incorporated in microspheres. The compositions are useful for chemoembolization, particularly for loco regional treatment of tumors.
First claim
Opening claim text (preview).
The invention claimed is: 1. A composition comprising nemorubicin hydrochloride incorporated in a microsphere system without adding any releasing adjuvant, wherein the microspheres are made from polymeric materials selected from the group consisting of sulphonate-modified N-Fil hydrogel polyvinyl alcohol (PVA), wherein the diameter of the microspheres range from 221 μm-291 μm. 2. A composition according to claim 1 , in which nemorubicin hydrochloride is loaded/…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8940334B2 cover?
- The present invention relates to pharmaceutical composition containing nemorubicin hydrochloride incorporated in microspheres. The compositions are useful for chemoembolization, particularly for loco regional treatment of tumors.
- Who is the assignee on this patent?
- Geroni Maria Cristina, Valota Olga, Martini Alessandro, and 2 more
- What technology area does this patent fall under?
- Primary CPC classification A61K9/0019. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).